Frequency and function of regulatory T cells after ischaemic stroke in humans
Authors:
- Jun YanJYJun Yan
- Stephen J. ReadSRStephen J. Read
- Robert D. HendersonRHRobert D. Henderson
- Renee HullRHRenee Hull
- John D. O'SullivanJOJohn D. O'Sullivan
- Pamela A. McCombePMPamela A. McCombe
- Judith M. GreerJGJudith M. Greer
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 243 (1-2) , 89-94
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Mechanisms Contributing to Cerebral Infarct Size after Stroke: Gender, Reperfusion, T Lymphocytes, and Nox2-Derived SuperoxideJournal of Cerebral Blood Flow & Metabolism, 2010
- The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemiaBiochemical and Biophysical Research Communications, 2009
- Stroke-induced immunodepression and post-stroke infections: Lessons from the preventive antibacterial therapy in stroke trialNeuroscience, 2009
- Regulatory T cells are key cerebroprotective immunomodulators in acute experimental strokeNature Medicine, 2009
- Hypoxia controls CD4+CD25+ regulatory T‐cell homeostasis via hypoxia‐inducible factor‐1αEuropean Journal of Immunology, 2008
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsJournal of Experimental Medicine, 2006
- Statin therapy and autoimmune disease: from protein prenylation to immunomodulationNature Reviews Immunology, 2006
- Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic strokeJournal of the Neurological Sciences, 2005
- Adoptive Transfer of Myelin Basic Protein–Tolerized Splenocytes to Naive Animals Reduces Infarct SizeStroke, 2003
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionThe Lancet, 1991